The development of high flux and solvent‐stable thin‐film composite (TFC) organic solvent nanofiltration (OSN) membranes was reported. A novel cross‐linked polyimide substrate, consisting of a thin skin layer with minimum solvent transport resistance and a sponge‐like sublayer structure that could withstand membrane compaction under high‐pressure was first fabricated. Then the solvent flux was significantly enhanced without compromising the solute rejection by the coupling effects of (1) the addition of triethylamine/camphorsulfonic acid into the monomer solution, and (2) the combined post‐treatments of glycerol/sodium dodecyl sulphate immersion and dimethyl sulfoxide (DMSO) filtration. Finally, the long‐term stability of the TFC membrane in aprotic solvents such as DMSO was improved by post‐crosslink thermal annealing. The novel TFC OSN membrane developed was found to have superior rejection to tetracycline (MW: 444 g/mol) but was very permeable to alcohols such as methanol (5.12 lm−2h−1bar−1) and aprotic solvents such as dimethylformamide (3.92 lm−2h−1bar−1) and DMSO (3.34 lm−2h−1bar−1).
No takes yet. Share an insight, caveat, or question.
Sun et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: